← Eichor
Study identifier: NCT06498115 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Norepinephrine on Maternal Hypotension After Combined Lumbar and Epidural Anaesthesia

Condition: Maternal Hypotension  ·  Sponsor: The Third People's Hospital of Bengbu

PhasePhase 4
Planned participants100
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersYes

About this study

Norepinephrine has emerged as a potential alternative for stabilizing blood pressure during spinal anesthesia for cesarean section, purportedly maintaining maternal heart rate and cardiac output more effectively than phenylephrine. However, its application as an intravenous bolus for treating hypotension remains underexplored. Consequently, this current investigation aimed to determine the ED50 and ED95 of norepinephrine for managing maternal hypotension during cesarean section. A prospective trial enrolled 100 patients undergoing elective delivery under spinal anesthesia, with norepinephrine dosage determined using the upper and lower sequential distribution method (UDM).

This description comes directly from the study's public registry record.

Talk to the study team

Chengfei Xu  ·  +8615255098850  ·  bbxcfpain@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Third People's Hospital of BengbuBengbu, Anhui, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06498115